Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bilirubin nanomedicine ameliorates the progression of experimental autoimmune encephalomyelitis by modulating dendritic cells
Authors
Keywords
Bilirubin nanoparticles, Reactive oxygen species, Experimental autoimmune encephalomyelitis, Multiple sclerosis, T cell differentiation, Th17 cell
Journal
JOURNAL OF CONTROLLED RELEASE
Volume 331, Issue -, Pages 74-84
Publisher
Elsevier BV
Online
2021-01-13
DOI
10.1016/j.jconrel.2021.01.019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bilirubin nanomedicine alleviates psoriatic skin inflammation by reducing oxidative stress and suppressing pathogenic signaling
- (2020) Hyeongseop Keum et al. JOURNAL OF CONTROLLED RELEASE
- Targeted Codelivery of an Antigen and Dual Agonists by Hybrid Nanoparticles for Enhanced Cancer Immunotherapy
- (2019) Linhua Zhang et al. NANO LETTERS
- The dual role of ROS in autoimmune and inflammatory diseases: Evidence from preclinical models
- (2018) Markus H. Hoffmann et al. FREE RADICAL BIOLOGY AND MEDICINE
- Multiple Sclerosis: Mechanisms and Immunotherapy
- (2018) Clare Baecher-Allan et al. NEURON
- Neuroinflammation: Microglia and T Cells Get Ready to Tango
- (2018) Sjoerd T. T. Schetters et al. Frontiers in Immunology
- Differentiation and Transmigration of CD4 T Cells in Neuroinflammation and Autoimmunity
- (2017) Sandip Ashok Sonar et al. Frontiers in Immunology
- Paeoniflorin Ameliorates Experimental Autoimmune Encephalomyelitis via Inhibition of Dendritic Cell Function and Th17 Cell Differentiation
- (2017) Han Zhang et al. Scientific Reports
- Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy
- (2016) Yonghyun Lee et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Piperlongumine Suppresses Dendritic Cell Maturation by Reducing Production of Reactive Oxygen Species and Has Therapeutic Potential for Rheumatoid Arthritis
- (2016) Youjun Xiao et al. JOURNAL OF IMMUNOLOGY
- Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells
- (2016) Reza Nosratabadi et al. Nanomedicine-Nanotechnology Biology and Medicine
- Experimental priming of encephalitogenic Th1/Th17 cells requires pertussis toxin-driven IL-1β production by myeloid cells
- (2016) Francesca Ronchi et al. Nature Communications
- NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress
- (2015) Becky A. Diebold et al. ANTIOXIDANTS & REDOX SIGNALING
- SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL
- (2015) Soo-Ho Choi et al. Autophagy
- Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
- (2015) Antonella Carambia et al. JOURNAL OF HEPATOLOGY
- Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction
- (2015) Marjan Gharagozloo et al. Nanomedicine-Nanotechnology Biology and Medicine
- Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis
- (2015) Gabriel Arellano et al. Frontiers in Immunology
- R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
- (2014) K. Schmitz et al. EMBO Molecular Medicine
- NADPH Oxidase Modifies Patterns of MHC Class II-Restricted Epitopic Repertoires through Redox Control of Antigen Processing
- (2014) E. R. O. Allan et al. JOURNAL OF IMMUNOLOGY
- Plumbagin suppresses dendritic cell functions and alleviates experimental autoimmune encephalomyelitis
- (2014) Kai Zhang et al. JOURNAL OF NEUROIMMUNOLOGY
- Lymphatic-targeted cationic liposomes: A robust vaccine adjuvant for promoting long-term immunological memory
- (2014) Ce Wang et al. VACCINE
- Custom Cerium Oxide Nanoparticles Protect against a Free Radical Mediated Autoimmune Degenerative Disease in the Brain
- (2013) Karin L. Heckman et al. ACS Nano
- Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
- (2013) Abdolmohamad Rostami et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells
- (2013) Y. Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms of Action of Adjuvants
- (2013) Sunita Awate et al. Frontiers in Immunology
- Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis
- (2012) A. Yeste et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)
- (2011) Cris S Constantinescu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function
- (2011) Anne Dudeck et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Increased generation of superoxide radicals in the blood of MS patients
- (2010) A. Glabiński et al. ACTA NEUROLOGICA SCANDINAVICA
- Differentiation of Effector CD4 T Cell Populations
- (2010) Jinfang Zhu et al. Annual Review of Immunology
- Characterizing the Dynamics of CD4+ T Cell Priming within a Lymph Node
- (2010) J. J. Linderman et al. JOURNAL OF IMMUNOLOGY
- The protective role of ROS in autoimmune disease
- (2009) Malin Hultqvist et al. TRENDS IN IMMUNOLOGY
- NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells
- (2008) A. R. Mantegazza et al. BLOOD
- Edaravone, a free radical scavenger, ameliorates experimental autoimmune encephalomyelitis
- (2008) Masayuki Moriya et al. NEUROSCIENCE LETTERS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search